Clinical Trial Update: Clinical Study of WT2725 in Patients With Advanced Malignancies [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for WT2725 in patients with advanced cancers; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• WT2725

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Cancer | Phase 1 | Status: COMPLETED | Results posted: 2019-04-05